PharVision Advisers’s Applovin APP Stock Holding History

PharVision Advisers’s Portfolio APP Stock Details APP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-894	Closed	-$290K	–	279
2024 Q4	$290K	Buy	+894	New	+$226K	0.24%	169

Other funds holding APP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's APP Position: Q1 2025 in Review

PharVision Advisers sold out of Applovin (APP) in Q1 2025, closing a stake of 894 shares — an estimated $290K sold.

PharVision Advisers first reported a position in APP in Q4 2024 and held it in 1 quarter. The position peaked at $290K in Q4 2024. 1,014 funds tracked by Wall St. Rank hold APP as of Q1 2025.

PharVision Advisers reported no remaining Applovin position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 894 Applovin shares in Q1 2025, an estimated $290K.
PharVision Advisers first reported a position in Applovin in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Applovin position peaked at $290K in Q4 2024.
1,014 funds tracked by Wall St. Rank held Applovin as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.